Literature DB >> 24076458

Molecular modeling and multispectroscopic studies of the interaction of mesalamine with bovine serum albumin.

Nahid Shahabadi1, Soraya Moradi Fili.   

Abstract

The interaction of mesalamine (5-aminosalicylic acid (5-ASA)) with bovine serum albumin (BSA) was investigated by fluorescence quenching, absorption spectroscopy, circular dichroism (CD) techniques, and molecular docking. Thermodynamic parameters (ΔH<0 and ΔS 0) indicated that the hydrogen bond and electrostatic forces played the major role in the binding of 5-ASA to BSA. The results of CD and UV-vis spectroscopy showed that the binding of this drug to BSA induces some conformational changes in BSA. Displacement experiments predicted that the binding of 5-ASA to BSA is located within domain III, Sudlows site 2, that these observations were substantiated by molecular docking studies. In addition, the docking result shows that the 5-ASA in its anionic form mainly interacts with Gln-416 residue through one hydrogen bond between H atom of 5-ASA anion and the adjacent O atom of the hydroxyl group of Gln-416.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BSA; Mesalamine; Molecular docking

Mesh:

Substances:

Year:  2013        PMID: 24076458     DOI: 10.1016/j.saa.2013.08.110

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  8 in total

1.  In vitro and in vivo cytotoxic activity and human serum albumin interaction for a methoxy-styryl-thiosemicarbazone.

Authors:  Otávio Augusto Chaves; Isabela S de Castro; Carla Marins Goulart; Myrtes S S Bellieny; José Carlos Netto-Ferreira; Juliana Echevarria-Lima; Aurea Echevarria
Journal:  Invest New Drugs       Date:  2019-01-19       Impact factor: 3.850

2.  Study of binding interaction of rivaroxaban with bovine serum albumin using multi-spectroscopic and molecular docking approach.

Authors:  Tanveer A Wani; Haitham AlRabiah; Ahmed H Bakheit; Mohd Abul Kalam; Seema Zargar
Journal:  Chem Cent J       Date:  2017-12-20       Impact factor: 4.215

3.  Spectrophotometric and molecular modelling studies on in vitro interaction of tyrosine kinase inhibitor linifanib with bovine serum albumin.

Authors:  Tanveer A Wani; Ahmed H Bakheit; Seema Zargar; Mohammed A Hamidaddin; Ibrahim A Darwish
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

4.  Induction of axial chirality in divanillin by interaction with bovine serum albumin.

Authors:  Diego Venturini; Aguinaldo Robinson de Souza; Ignez Caracelli; Nelson Henrique Morgon; Luiz Carlos da Silva-Filho; Valdecir Farias Ximenes
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

5.  Spectroscopic, thermodynamic and molecular docking studies of bovine serum albumin interaction with ascorbyl palmitate food additive.

Authors:  Yousef Sohrabi; Vahid Panahi-Azar; Abolfazl Barzegar; Jafar Ezzati Nazhad Dolatabadi; Parvin Dehghan
Journal:  Bioimpacts       Date:  2017-08-30

6.  Study of Interactions of an Anticancer Drug Neratinib With Bovine Serum Albumin: Spectroscopic and Molecular Docking Approach.

Authors:  Tanveer A Wani; Ahmed H Bakheit; M A Abounassif; Seema Zargar
Journal:  Front Chem       Date:  2018-03-07       Impact factor: 5.221

7.  Spectroscopic and molecular modeling studies of binding interaction between bovine serum albumin and roflumilast.

Authors:  Tanveer A Wani; Ahmed H Bakheit; Mohammed Nazam Ansari; Abdul-Rahman A Al-Majed; Bakr M Al-Qahtani; Seema Zargar
Journal:  Drug Des Devel Ther       Date:  2018-08-28       Impact factor: 4.162

8.  A chromatographic approach to development of 5-aminosalicylate/folic acid fixed-dose combinations for treatment of Crohn's disease and ulcerative colitis.

Authors:  Mario-Livio Jeličić; Edvin Brusač; Daniela Amidžić Klarić; Biljana Nigović; Nikša Turk; Ana Mornar
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.